S&P 500 7,407 -1.69% Nasdaq 25,118 -2.95% Dow Jones 51,730 -1.57% FTSE 100 10,639 +0.63% DAX 24,763 -0.61% Nikkei 225 66,423 -0.62% Hang Seng 25,211 +0.81% WTI Crude 91.89 +10.40% Gold 4,050 +0.99% US 10-Year Treasury Yield 4.701 +3.52% S&P 500 7,407 -1.69% Nasdaq 25,118 -2.95% Dow Jones 51,730 -1.57% FTSE 100 10,639 +0.63% DAX 24,763 -0.61% Nikkei 225 66,423 -0.62% Hang Seng 25,211 +0.81% WTI Crude 91.89 +10.40% Gold 4,050 +0.99% US 10-Year Treasury Yield 4.701 +3.52%

LATEST

We're ready to move on from Dover after the industrial conglomerate's weak quarter●Three crypto protocols lose $35.55mn in day of bridge exploits●Bosun Tijani launches ATLAS Network to accelerate Africa’s AI language models●An AI now judges every move Rubrik's agents make, its AI chief said at VB Transform 2026 — but no one's measured if the judge is right●Gold prices today, Thursday, July 23, 2026: Gold price opens below $4,100 as inflation worries clash with safe-haven demand●Blackstone CEO Stephen Schwarzman says firm is 'mindful' of 'excessive exuberance' in AI●Goldman Sachs Backs the Clarity Act, Splitting Wall Street Over Crypto Rules●Why ServiceNow’s stock is a rare bright spot while the rest of tech stumbles●We're ready to move on from Dover after the industrial conglomerate's weak quarter●Three crypto protocols lose $35.55mn in day of bridge exploits●Bosun Tijani launches ATLAS Network to accelerate Africa’s AI language models●An AI now judges every move Rubrik's agents make, its AI chief said at VB Transform 2026 — but no one's measured if the judge is right●Gold prices today, Thursday, July 23, 2026: Gold price opens below $4,100 as inflation worries clash with safe-haven demand●Blackstone CEO Stephen Schwarzman says firm is 'mindful' of 'excessive exuberance' in AI●Goldman Sachs Backs the Clarity Act, Splitting Wall Street Over Crypto Rules●Why ServiceNow’s stock is a rare bright spot while the rest of tech stumbles●

Companies

Eli Lilly Will File For Retatrutide Approval—As Study Shows Average Weight Loss Of 56 Pounds

Forbes - Business · 2h ago · 🇬🇧 United Kingdom

Eli Lilly Will File For Retatrutide Approval—As Study Shows Average Weight Loss Of 56 Pounds

Eli Lilly will seek regulatory approval for retatrutide, a powerful weight loss drug that a new study shows helped people lose nearly 56 pounds on average.

Read the full story at Forbes - Business →

More Companies

We're ready to move on from Dover after the industrial conglomerate's weak quarter

Earnings · 29m ago

Why Do Russia’s Wildberries Warehouses Burn So Fiercely?

Forbes - Business · 1h ago

From Credit Bureaus To Trust Bureaus: The Next Era Of Digital Trust Verification

Forbes - Business · 1h ago

$100 Oil Is Back, Raising The Specter Of $5 Gasoline Prices To Come

Forbes - Business · 1h ago